Where It Comes From
Chinomethionate (quinomethionate) was developed in the 1960s as a fungicide for controlling various fungal diseases in agriculture, particularly on fruits and vegetables [1]. The compound was adopted for use in crop protection programs where contact fungicides provided inadequate disease control. Chinomethionate saw moderate use in agriculture globally, though never achieving the widespread adoption of other fungicide classes. Environmental and health concerns led to periodic regulatory reviews and restrictions in some jurisdictions [2]. Today, chinomethionate remains available in some markets despite decreased use compared to newer fungicide alternatives [3].
How You Are Exposed
Agricultural workers applying chinomethionate fungicides face occupational exposure through inhalation and dermal contact. Greenhouse and nursery employees encounter exposure during fungicide application. Fruit and vegetable pickers may contact residues on harvested crops. Environmental exposure occurs through contaminated water and soil.
Why It Matters
Chinomethionate shows moderate toxicity in animal studies with potential neurological and systemic effects. The compound may have sensitizing properties. Animal studies suggest potential reproductive and developmental effects at high doses. Environmental persistence in soil and water raises chronic exposure concerns.
Who Is at Risk
Agricultural workers applying chinomethionate fungicides face occupational exposure risk. Greenhouse and nursery workers encounter chronic exposure. Fruit and vegetable workers may have residue contact. Vulnerable populations include pregnant women and children in agricultural areas.
How to Lower Your Exposure
References
- [1][1] Kiffer, E., & Morelet, M. (1997). 'The Deuteromycetes: Mitosporic Fungi.' Science Publishers.
- [2][2] Fungicide Resistance Action Committee (2013). 'FRAC Mode of Action Classification.' International Fungicide Resistance Organization.
- [3][3] EPA (2005). 'Chinomethionate—Pesticide Fact Sheet.' Environmental Protection Agency.
Recovery & Clinical Information
Body Half-Life
Chinomethionate absorption varies depending on exposure route. Hepatic metabolism produces metabolites. The elimination half-life is estimated at 20-40 hours in mammals. Urinary excretion is the primary elimination route.
Testing & Biomarkers
Occupational exposure is detected through air and dermal monitoring. Residue analysis of food and water identifies dietary and environmental exposure. Medical evaluation focuses on neurological health and reproductive status. Baseline and periodic assessments detect chronic effects.
Interventions
Acute exposure management includes decontamination and supportive care. Contact dermatitis is managed with emollients and topical corticosteroids. Chronic exposure management focuses on occupational hygiene and health monitoring. Medical interventions address specific symptom manifestations.
Recovery Timeline
Acute irritation symptoms develop within 2-6 hours of significant exposure. Systemic effects develop over hours to days. Chronic health effects accumulate over weeks to months. Recovery from acute exposure occurs within 1-2 days.
Recovery References
- [1][1] Kiffer, E., & Morelet, M. (1997). 'The Deuteromycetes: Mitosporic Fungi.' Science Publishers.
- [2][2] Fungicide Resistance Action Committee (2013). 'FRAC Mode of Action Classification.' International Fungicide Resistance Organization.
- [3][3] EPA (2005). 'Chinomethionate—Pesticide Fact Sheet.' Environmental Protection Agency.